Figures & data
Figure 1. Illustration for the preparation of pH-responsive Spe@HNPs with layer-by-layer structure and drug delivery for acute lung infection treatment.
![Figure 1. Illustration for the preparation of pH-responsive Spe@HNPs with layer-by-layer structure and drug delivery for acute lung infection treatment.](/cms/asset/659af2bd-336f-494e-a066-91e11cb0f709/idrd_a_2000676_f0001_c.jpg)
Figure 2. Characterization of Spe@HNPs system. Particle size (A), polydispersity index (PDI, B), and charge reversal in zeta-potential (C) of Spe-loaded liposomes, single-layered NPs, and Spe@NPs. The data are shown as mean ± s.d. (n = 3 independent experiments). (D) SEM image of Spe@NPs (insert: scale bar: 100 nm).
![Figure 2. Characterization of Spe@HNPs system. Particle size (A), polydispersity index (PDI, B), and charge reversal in zeta-potential (C) of Spe-loaded liposomes, single-layered NPs, and Spe@NPs. The data are shown as mean ± s.d. (n = 3 independent experiments). (D) SEM image of Spe@NPs (insert: scale bar: 100 nm).](/cms/asset/6c9dd046-f917-45cc-b7ab-cce2ecb4a3f8/idrd_a_2000676_f0002_c.jpg)
Table 1. Spe loading capacity of Spe@NPs at different mass ratios.
Figure 3. Evaluation of pH-responsive property and stability of Spe@NPs system. The hydrodynamic diameters (A) and zeta-potential (B) of Spe@HNPs at different conditions. Hydrodynamic diameters (C) and PDI (D) of Spe@HNPs after incubation in PBS (pH 7.4) with 20% FBS at 37 °C for 5 days. The data are shown as mean ± s.d. (n = 3 independent experiments).
![Figure 3. Evaluation of pH-responsive property and stability of Spe@NPs system. The hydrodynamic diameters (A) and zeta-potential (B) of Spe@HNPs at different conditions. Hydrodynamic diameters (C) and PDI (D) of Spe@HNPs after incubation in PBS (pH 7.4) with 20% FBS at 37 °C for 5 days. The data are shown as mean ± s.d. (n = 3 independent experiments).](/cms/asset/c7d51178-a79b-4528-a671-a53cd9292d1e/idrd_a_2000676_f0003_c.jpg)
Figure 4. In vitro pH-triggered drug release performance of Spe@HNPs at pH 7.4 and 6.0. The data are shown as mean ± s.d. (n = 3 independent experiments).
![Figure 4. In vitro pH-triggered drug release performance of Spe@HNPs at pH 7.4 and 6.0. The data are shown as mean ± s.d. (n = 3 independent experiments).](/cms/asset/e62e124b-7550-42d6-a296-ca420cfa25bf/idrd_a_2000676_f0004_c.jpg)
Figure 5. Therapeutic efficacy of Spe@HNPs for an acute lung infection. CFU of bacteria (A), leukocyte number (B), protein content (C), TNF-α (D), IL-1β (E), and IL-6 (F) in BALF of mice infected by MRSA BAA40 20 h after the treatments with PBS, HNPs, free drug or Spe@HNPs. The data are shown as mean ± s.d. (n = 5 independent experiments). P values: *p < .05, **p < .01, ***p < .001, N.S. (no significant difference) p > .05.
![Figure 5. Therapeutic efficacy of Spe@HNPs for an acute lung infection. CFU of bacteria (A), leukocyte number (B), protein content (C), TNF-α (D), IL-1β (E), and IL-6 (F) in BALF of mice infected by MRSA BAA40 20 h after the treatments with PBS, HNPs, free drug or Spe@HNPs. The data are shown as mean ± s.d. (n = 5 independent experiments). P values: *p < .05, **p < .01, ***p < .001, N.S. (no significant difference) p > .05.](/cms/asset/d1a5d0d5-f52d-4e9f-b38c-e9c7813a512d/idrd_a_2000676_f0005_c.jpg)
Table 2. Summary of MIC of samples against S. aureus and MRSA BAA40.